Table 4: The predictive power of EGFR, Her2/neu, phospho-EGFR, phospho-Her2/neu in breast cancer survival assessment on
this study cohort (N=235). Six parameters for antibody measurements were included in the analysis of phospho-EGFR,
phospho-Her2/neu, and EGFR. P value represents the statistical significance of the improvement over the control analysis
| Analysis |
Age |
ER |
PR |
Her2/neu |
pHer2/neu |
EGFR |
pEGFR |
F-measure |
Improvement |
| 1 |
x |
x |
x |
|
|
|
|
0.514 |
|
| 2 |
x |
x |
x |
x |
|
x |
|
0.561 |
p < 0.15 |
| 3 |
x |
x |
x |
|
x |
|
x |
0.590 |
p < 0.05 |
| 4 |
x |
x |
x |
x |
x |
x |
x |
0.575 |
p < 0.09 |